Insulet
$131.69Change from previous close: +0.69%Absolute change: +$0.90
At a glance
- Revenue growth
- +30.73%
- 2025 vs 2024
- Net income growth
- −40.93%
- 2025 vs 2024
- Net margin
- 9.1%
- 2024: 20.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 2,708 | 2,072 | 1,697 | 1,305 | — |
| Cost of revenue | 768 | 626 | 537 | 500 | — |
| Gross profit | 1,940 | 1,446 | 1,160 | 806 | — |
| Selling, general and administrative | 1,165 | 917 | 735 | 588 | — |
| Research and development | 301 | 220 | 205 | 180 | — |
| Operating income | 474 | 309 | 220 | 37.6 | — |
| EBIT | 399 | 343 | 251 | 45.8 | — |
| EBITDA | 489 | 424 | 324 | 109 | — |
| Interest expense | 59.4 | 42.7 | 36.2 | 36.0 | — |
| Pre-tax income | 340 | 300 | 215 | 9.8 | — |
| Income tax | 92.4 | -118 | 8.3 | 5.2 | — |
| Net income | 247 | 418 | 206 | 4.6 | — |
| Net income to common shareholders | 247 | 418 | 206 | 4.6 | — |
| Basic EPS | 3.51 | 5.97 | 2.96 | 0.07 | — |
| Diluted EPS | 3.48 | 5.78 | 2.94 | 0.07 | — |
| Average shares (basic) | 70.3 | 70.1 | 69.8 | 69.4 | — |
| Average shares (diluted) | 71.9 | 73.9 | 73.6 | 69.9 | — |